Sign in

CIK 0000882095

  • Large accelerated filer

GILEAD SCIENCES, INC.

Sign in to watch
Ticker
GILD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943047598
Phone
+1 650-574-3000
Business address
333 LAKESIDE DR, FOSTER CITY, CA, 94404
Former names
GILEAD SCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$41,560,956
in 13 filings, $41.6M under 10b5-1 plans

Net −$41,560,956. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-11-16 Mercier Johanna Chief Comm & Corp Aff Officer Exercise or conversion 10b5-1 +25,000 $72.34 $1.8M 138,684
2026-11-16 Mercier Johanna Chief Comm & Corp Aff Officer Sale 10b5-1 −13,922 $169.97 $2.4M 124,762
2026-11-16 Mercier Johanna Chief Comm & Corp Aff Officer Sale 10b5-1 −13,178 $171.09 $2.3M 111,584
2026-11-16 Mercier Johanna Chief Comm & Corp Aff Officer Sale 10b5-1 −900 $171.69 $155K 110,684
2026-11-16 Mercier Johanna Chief Comm & Corp Aff Officer Exercise or conversion · Non-qualified Stock Option (Right to Buy) 10b5-1 −25,000 44,960
2026-11-16 Dickinson Andrew D Chief Financial Officer Sale 10b5-1 −3,000 $171.47 $514K 158,096
2026-11-12 Kramer Kelly A. Director Exercise or conversion 10b5-1 +10,376 $66.92 $694K 11,715
2026-11-12 Kramer Kelly A. Director Sale 10b5-1 −1,676 $168.23 $282K 10,039
2026-11-12 Kramer Kelly A. Director Sale 10b5-1 −3,800 $169.44 $644K 6,239
2026-11-12 Kramer Kelly A. Director Sale 10b5-1 −4,700 $170.49 $801K 1,539
2026-11-12 Kramer Kelly A. Director Sale 10b5-1 −200 $171.44 $34K 1,339
2026-11-12 Kramer Kelly A. Director Exercise or conversion · Non-qualified Stock Option (Right to Buy) 10b5-1 −10,376 0
2026-11-06 Cain Wettan Keeley M EVP Gen Counsel, Legal & Comp Sale 10b5-1 −3,399 $164.11 $558K 5,360
2026-11-05 O'Day Daniel Patrick Chairman & CEO Exercise or conversion 10b5-1 +9,810 $72.34 $710K 561,493
2026-11-05 O'Day Daniel Patrick Chairman & CEO Sale 10b5-1 −9,810 $175.17 $1.7M 551,683
2026-11-05 O'Day Daniel Patrick Chairman & CEO Exercise or conversion · Non-qualified Stock Option (Right to Buy) 10b5-1 −9,810 128,310
2026-11-04 O'Day Daniel Patrick Chairman & CEO Exercise or conversion 10b5-1 +102,619 $72.34 $7.4M 654,302
2026-11-04 O'Day Daniel Patrick Chairman & CEO Sale 10b5-1 −102,619 $175.16 $18.0M 551,683
2026-11-04 O'Day Daniel Patrick Chairman & CEO Exercise or conversion · Non-qualified Stock Option (Right to Buy) 10b5-1 −102,619 138,120
2026-11-02 O'Day Daniel Patrick Chairman & CEO Sale 10b5-1 −1,600 $167.40 $268K 565,083

Page 1 of 44 · 870 trades